Form 8-K - Current report:
SEC Accession No. 0001104659-25-050435
Filing Date
2025-05-19
Accepted
2025-05-19 16:05:20
Documents
13
Period of Report
2025-05-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515549d1_8k.htm   iXBRL 8-K 41480
2 EXHIBIT 10.1 tm2515549d1_ex10-1.htm EX-10.1 99389
  Complete submission text file 0001104659-25-050435.txt   332484

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA coll-20250515.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE coll-20250515_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coll-20250515_pre.xml EX-101.PRE 22373
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2515549d1_8k_htm.xml XML 3700
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37372 | Film No.: 25963867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)